|
|
M Lehto, T Tuomi, M M Mahtani, E Widén, C Forsblom, L Sarelin, M Gullström, B Isomaa, M Lehtovirta, A Hyrkkö, T Kanninen, M Orho, S Manley, R C Turner, T Brettin, A Kirby, J Thomas, G Duyk, E Lander, M R Taskinen, L Groop
J Clin Invest. 1997;
99(4):582
doi:10.1172/JCI119199
Abstract |
Full text
| PDF

M
aturity-onset diabetes of the young (MODY) type 3 is a dominantly inherited form of diabetes, which is often misdiagnosed as non-insulin-dependent diabetes mellitus (NIDDM) or insulin-dependent diabetes mellitus (IDDM). Phenotypic analysis of members from four large Finnish MODY3 kindreds (linked to chromosome 12q with a maximum lod score of 15) revealed a severe impairment in insulin secretion, which was present also in those normoglycemic family members who had inherited the MODY3 gene. In contrast to patients with NIDDM, MODY3 patients did not show any features of the insulin resistance syndrome. They could be discriminated from patients with IDDM by lack of glutamic acid decarboxylase antibodies (GAD-Ab). Taken together with our recent findings of linkage between this region on chromosome 12 and an insulin-deficient form of NIDDM (NIDDM2), the data suggest that mutations at the MODY3/NIDDM2 gene(s) result in a reduced insulin secretory response, that subsequently progresses to diabetes and underlines the importance of subphenotypic classification in studies of diabetes.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(40)
| Title and authors |
Publication |
Year |
Characterization of beta cell and incretin function in patients with MODY1 (HNF4A MODY) and MODY3 (HNF1A MODY) in a Swedish patient collection
E. Ekholm, N. Shaat, J. J. Holst
|
Acta Diabetol
|
2011 |
Identification of HNF1A-MODY and HNF4A-MODY in Irish families: Phenotypic characteristics and therapeutic implications
M.P. Kyithar, S. Bacon, K.K. Pannu, S.R. Rizvi, K. Colclough, S. Ellard, M.M. Byrne
|
Diabetes & Metabolism
|
2011 |
Monogenic diabetes: information seeking and genetic testing access via e-mail
M Shepherd
|
Eur. Diab. Nursing
|
2010 |
Stopping insulin injections following genetic testing in diabetes: impact on identity
M. Shepherd
|
Diabetic Medicine
|
2010 |
An investigation of serum concentration of apoM as a potential MODY3 marker using a novel ELISA
C. Cervin, O. Axler, J. Holmkvist, P. Almgren, E. Rantala, T. Tuomi, L. Groop, B. Dahlbäck, E. Karlsson
|
Journal of Internal Medicine
|
2010 |
A genetic diagnosis ofHNF1Adiabetes alters treatment and improves glycaemic control in the majority of insulin-treated patients
M. Shepherd, B. Shields, S. Ellard, O. Rubio-Cabezas, A. T. Hattersley
|
Diabetic Medicine
|
2009 |
Phenotypical aspects of maturity-onset diabetes of the young (MODY diabetes) in comparison with Type 2 diabetes mellitus (T2DM) in children and adolescents: experience from a large multicentre database
E. Schober, B. Rami, M. Grabert, A. Thon, Th. Kapellen, Th. Reinehr, R. W. Holl
|
Diabetic Medicine
|
2009 |
Genetic testing clarifies diagnosis and treatment in a family with bothHNF1Aand type 1 diabetes
M Shepherd
|
Pract. Diab. Int.
|
2009 |
Role of HNF-1α and HNF-1β on insulin, IGF-1 and other potential target genes
Sachiko Kitanaka
|
Expert Rev Endocrinol Metab
|
2008 |
Mutation Screening of HNF-1α Gene in Korean Women with Gestational Diabetes Mellitus
Hun-Sung Kim, Sun-Hee Hwang, Eun-Sun Choi, So-Young Park, Chang-Hoon Yim, Ki-Ok Han, Hyun-Koo Yoon, Ho-Yeon Chung, Kyung-Seon Kim, Jeong Bok, Jong-Young Lee, Sung-Hoon Kim
|
Korean Diabetes J
|
2008 |
|